The Journey of Roe Roe: A Brave Girl Battling Leukemia
... Background aims: Efforts to safely and effectively treat acute myeloid leukemia (AML) by targeting a single ... TP53 is the most commonly mutated gene in human cancer. Presence of “multi-hit” TP53 mutations is associated with ... As a plenary abstract at the 2021 ASH Annual Meeting, Alba Rodriguez-Meira, PhD-c, of MRC Weatherall Institute of ... Each week on DocWire News, editors bring you the latest in oncology news and cancer research. In case you missed it, ... A review and meta-analysis published in Clinical Lymphoma, Myeloma & Leukemia, investigated the association between ... Did you know September is Blood Cancer Awareness Month? This month, take the time to learn more about this disease, ... Each week on DocWire, editors bring you the latest news and research in hematology and oncology. Here are this week's ... A retrospective study published in Cancer Medicine provided real-world data on patients with chronic myelomonocytic ... When physicians suspect a diagnosis of certain conditions, a referral to a hematologist is warranted. A research team in Norway found that previous hematological malignancies were associated with a subsequent diagnosis of ... A study assessed the mechanisms of CD20 monoclonal antibodies (mAbs) with B-cell receptor (BCR)-associated kinase (BAKi) ... Researchers from the University of Alberta have identified a new mechanism of cell signal inhibition that could prove ... A study which appeared in the journal Oncotarget sheds light on why people with Down syndrome are at higher risk of ... A bispecific chimeric antigen receptor (CAR) T-cell therapy targeting CD19 and CD22 induced remission in adult patients ... The U.S. Food and Drug Administration (FDA) approved Imbruvica® (ibrutinib) in combination with Rituxan® (rituximab) ... An article published in Leukemia Research outlined factors to consider when treating patients with acute leukemia during ... An anti-CD19 chimeric antigen receptor (CAR) T-cell-transduced natural killer (NK) therapy induced responses in patients ... A study published in JNCI Cancer Spectrum observed an increased risk of prostate cancer, thyroid cancer, and leukemia in ... Patients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) who are treated with anthracyclines ...